FDA Inspection 1165194 — Adam M. Sun, M.D

Adam M. Sun, M.D — FEI 3017853342

The FDA completed an inspection of Adam M. Sun, M.D on February 25, 2022 in Rosemead, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 25, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rosemead, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752021 CFR 312.64(b)Safety reports
752621 CFR 312.62(a)Accountability records
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance